Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-028870
Filing Date
2018-05-15
Accepted
2018-05-15 16:07:06
Documents
46
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv492549_10q.htm 10-Q 392016
2 EXHIBIT 31.1 tv492549_ex31-1.htm EX-31.1 11608
3 EXHIBIT 31.2 tv492549_ex31-2.htm EX-31.2 11711
4 EXHIBIT 32.1 tv492549_ex32-1.htm EX-32.1 5629
5 EXHIBIT 32.2 tv492549_ex32-2.htm EX-32.2 5690
  Complete submission text file 0001144204-18-028870.txt   3011999

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aphb-20180331.xml EX-101.INS 785482
7 XBRL TAXONOMY EXTENSION SCHEMA aphb-20180331.xsd EX-101.SCH 25608
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aphb-20180331_cal.xml EX-101.CAL 28247
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aphb-20180331_def.xml EX-101.DEF 65744
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aphb-20180331_lab.xml EX-101.LAB 195804
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aphb-20180331_pre.xml EX-101.PRE 163813
Mailing Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130
Business Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130 804-827-2524
AmpliPhi Biosciences Corp (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37544 | Film No.: 18836436
SIC: 2836 Biological Products, (No Diagnostic Substances)